• Je něco špatně v tomto záznamu ?

Influence of a 2-week transcutaneous auricular vagus nerve stimulation on memory: findings from a randomized placebo controlled trial in non-clinical adults

V. Cibulcova, J. Koenig, M. Jackowska, VK. Jandackova

. 2024 ; 34 (4) : 447-462. [pub] 20240722

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články, randomizované kontrolované studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc24019459

Grantová podpora
GACR17-22346Y Grantová Agentura České Republiky
SGS07/LF/2023 Student Grant Award
CZ.02.1.01/0.0/0.0/16_019/0000798 Operational program Research, development and education

PURPOSE: Memory plays an essential role in daily life and is one of the first functions to deteriorate in cognitive impairment and dementia. Transcutaneous vagus nerve stimulation (tVNS) is a promising therapeutic method; however, its ability to enhance memory is underexplored, especially considering long-term stimulation. We aimed to investigate the effect of a 2-week course of auricular tVNS (taVNS) on memory in a non-clinical population. METHODS: This single-blind randomized placebo-wait-list controlled trial recruited 76 participants (30 men; mean age 48.32 years) and randomized them into four groups: early active/sham taVNS and late active/sham taVNS. Participation in the study lasted 4 weeks; early groups underwent 2 weeks intervention immediately following the first study site visit (days 0-13) and late groups 2 weeks after the first study site visit (days 14-27). Active and sham taVNS included 2 weeks of daily 4-h neurostimulation at the tragus or earlobe, respectively. To assess memory, we used the Rey Auditory Verbal Learning Test. RESULTS: Two weeks of active taVNS, but not sham taVNS, improved immediate recall and short-term memory score both in early and late groups. Furthermore, the improvements persisted over subsequent follow-up in early active taVNS. Importantly, the effect of active taVNS was superior to sham for immediate recall in both early and late groups. There were no statistical differences in delayed recall. CONCLUSION: Our findings suggest that taVNS has potential to improve memory, particularly immediate recall, and may be an effective method in preventing memory loss and mitigating cognitive aging.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24019459
003      
CZ-PrNML
005      
20250311124247.0
007      
ta
008      
241015s2024 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s10286-024-01053-0 $2 doi
035    __
$a (PubMed)39039354
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Cibulcová, Veronika $u Department of Epidemiology and Public Health, Faculty of Medicine, University of Ostrava, Syllabova 19, Ostrava, 703 00, Czech Republic. Veronika.Cibulcova@osu.cz $u Department of Human Movement Studies, Faculty of Education, University of Ostrava, Ostrava, Czech Republic. Veronika.Cibulcova@osu.cz $1 https://orcid.org/0000000294680195 $7 xx0330017
245    10
$a Influence of a 2-week transcutaneous auricular vagus nerve stimulation on memory: findings from a randomized placebo controlled trial in non-clinical adults / $c V. Cibulcova, J. Koenig, M. Jackowska, VK. Jandackova
520    9_
$a PURPOSE: Memory plays an essential role in daily life and is one of the first functions to deteriorate in cognitive impairment and dementia. Transcutaneous vagus nerve stimulation (tVNS) is a promising therapeutic method; however, its ability to enhance memory is underexplored, especially considering long-term stimulation. We aimed to investigate the effect of a 2-week course of auricular tVNS (taVNS) on memory in a non-clinical population. METHODS: This single-blind randomized placebo-wait-list controlled trial recruited 76 participants (30 men; mean age 48.32 years) and randomized them into four groups: early active/sham taVNS and late active/sham taVNS. Participation in the study lasted 4 weeks; early groups underwent 2 weeks intervention immediately following the first study site visit (days 0-13) and late groups 2 weeks after the first study site visit (days 14-27). Active and sham taVNS included 2 weeks of daily 4-h neurostimulation at the tragus or earlobe, respectively. To assess memory, we used the Rey Auditory Verbal Learning Test. RESULTS: Two weeks of active taVNS, but not sham taVNS, improved immediate recall and short-term memory score both in early and late groups. Furthermore, the improvements persisted over subsequent follow-up in early active taVNS. Importantly, the effect of active taVNS was superior to sham for immediate recall in both early and late groups. There were no statistical differences in delayed recall. CONCLUSION: Our findings suggest that taVNS has potential to improve memory, particularly immediate recall, and may be an effective method in preventing memory loss and mitigating cognitive aging.
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé středního věku $7 D008875
650    12
$a vagová stimulace $x metody $7 D055536
650    12
$a transkutánní elektrická neurostimulace $x metody $7 D004561
650    _2
$a jednoduchá slepá metoda $7 D016037
650    _2
$a dospělí $7 D000328
650    12
$a paměť $x fyziologie $7 D008568
655    _2
$a časopisecké články $7 D016428
655    _2
$a randomizované kontrolované studie $7 D016449
700    1_
$a Koenig, Julian $u Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Faculty of Medicine, University of Cologne, University Hospital Cologne, Cologne, Germany $1 https://orcid.org/0000000310099625
700    1_
$a Jackowska, Marta $u Faculty of Psychology, SWPS University, Sopot, Poland $1 https://orcid.org/0000000229300483
700    1_
$a Jandackova, Vera Kr $u Department of Epidemiology and Public Health, Faculty of Medicine, University of Ostrava, Syllabova 19, Ostrava, 703 00, Czech Republic $u Department of Human Movement Studies, Faculty of Education, University of Ostrava, Ostrava, Czech Republic $1 https://orcid.org/0000000208923657 $7 osd2015855258
773    0_
$w MED00007493 $t Clinical autonomic research : official journal of the Clinical Autonomic Research Society $x 1619-1560 $g Roč. 34, č. 4 (2024), s. 447-462
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39039354 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241015 $b ABA008
991    __
$a 20250311124255 $b ABA008
999    __
$a ok $b bmc $g 2201977 $s 1231432
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 34 $c 4 $d 447-462 $e 20240722 $i 1619-1560 $m Clinical autonomic research : official journal of the Clinical Autonomic Research Society $n Clin Auton Res $x MED00007493
GRA    __
$a GACR17-22346Y $p Grantová Agentura České Republiky
GRA    __
$a SGS07/LF/2023 $p Student Grant Award
GRA    __
$a CZ.02.1.01/0.0/0.0/16_019/0000798 $p Operational program Research, development and education
LZP    __
$a Pubmed-20241015

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...